The likelihood of a patient developing type 2 diabetes while on rheumatoid arthritis (RA) medication known as glucocorticoids increases in relation to the dosage, duration and timing of steroids, according to a new study published in the journal Arthritis and Rheumatology. Glucocorticoid therapy is prescribed to about half of all patients with rheumatoid arthritis, a chronic inflammatory disorder affecting many joints including those in the hands and feet. Diabetes is a side effect of glucocorticoids. The medication has been used since 1948 to treat flare-ups in joint pain. It is also used for longer periods at low doses to help ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.